title: The association between apelin-12 levels and paroxysmal supraventricular tachycardia.
abstract: OBJECTIVE
  Our aim was to investigate the apelin-12 levels in patients with atrioventricular tachyarrhythmias and compare with those in patients with lone atrial fibrillation.
  
  
  METHODS
  Forty four patients with supraventricular tachycardia as atrial fibrillation, 44 patients with paroxysmal supraventricular tachycardia (P-SVT) as atrioventricular tachyarrhythmias, including atrioventricular nodal reentrant tachycardia or atrioventricular reentrant tachycardia, and 30 age- and sex-matched healthy individuals were included in the study.
  
  
  RESULTS
  The apelin-12 levels were significantly lower in both atrial fibrillation and P-SVT groups than control group. In post-hoc analysis, there was no significant difference in apelin-12 levels between atrial fibrillation and P-SVT groups (P = 0.9). Patients in atrial fibrillation group and patients in P-SVT group had significantly lower apelin-12 levels than control group, separately (P < 0.001 and P < 0.001, respectively). The sensitivity and specificity values of the apelin-12 levels for predicting SVT, including both atrial fibrillation and atrioventricular reentrant tachycardia or atrioventricular nodal reentrant tachycardia were 64.77 and 90%, respectively (cut-off value was 0.87). The area under the receiver operator characteristic curve was 0.834 for the apelin-12 levels (P = 0.0001).
  
  
  CONCLUSIONS
  Apelin-12 levels are lower in patients with atrial fibrillation and P-SVT than control groups. Lower apelin levels in patients with atrial fibrillation and P-SVT would be expected to result in a decrease in the conduction velocity.
authors.affiliation: aDepartment of Emergency bDepartment of Cardiology cDepartment of Cardiovascular Surgery, Elazig Education and Research Hospital dDepartment of Biochemistry, Firat University Medical Faculty, Elazig, Turkey.
authors.forename: Mehtap
authors.initials: M
authors.lastname: Gurger
authors.forename: Ahmet
authors.initials: A
authors.lastname: Celik
authors.forename: Mehmet
authors.initials: M
authors.lastname: Balin
authors.forename: Evrim
authors.initials: E
authors.lastname: Gul
authors.forename: Mehmet A
authors.initials: MA
authors.lastname: Kobat
authors.forename: Kazim B
authors.initials: KB
authors.lastname: Bursali
authors.forename: Mustafa
authors.initials: M
authors.lastname: Sahan
authors.forename: Umut
authors.initials: U
authors.lastname: Gumusay
authors.forename: Cagdas
authors.initials: C
authors.lastname: Can
authors.forename: Ilyas M
authors.initials: IM
authors.lastname: Celiker
authors.forename: Suna
authors.initials: S
authors.lastname: Aydin
authors.forename: Suleyman
authors.initials: S
authors.lastname: Aydin
mesh_terms: D000328:Adult; D001281:Atrial Fibrillation / Q000097:blood / Q000503:physiopathology; D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D005260:Female; D006339:Heart Rate / Q000502:physiology; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D013617:Tachycardia, Supraventricular / Q000097:blood* / Q000175:diagnosis / Q000503:physiopathology
chemical_list: D015415:Biomarkers; D036341:Intercellular Signaling Peptides and Proteins; C495200:apelin-12 peptide